Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Высокоэффективное РНК-направляемое редактирование генома в клетках человека посредством доставки очищенных рибонуклеопротеинов Cas9
2014-04-02
SCID: 54.1/qqrbgj3c
Discuss with AI
Cas9 ribonucleoproteinsRGEN RNP deliveryRNA-guided engineered nucleaseshuman pluripotent stem cellsoff-target effects
Figures from the paper
Abstract (AI)
RNA-guided engineered nucleases (RGENs) derived from the prokaryotic adaptive immune system known as CRISPR (clustered, regularly interspaced, short palindromic repeat)/Cas (CRISPR-associated) enable genome editing in human cell lines, animals, and plants, but are limited by off-target effects and unwanted integration of DNA segments derived from plasmids encoding Cas9 and guide RNA at both on-target and off-target sites in the genome. Here, we deliver purified recombinant Cas9 protein and guide RNA into cultured human cells including hard-to-transfect fibroblasts and pluripotent stem cells. RGEN ribonucleoproteins (RNPs) induce site-specific mutations at frequencies of up to 79%, while reducing off-target mutations associated with plasmid transfection at off-target sites that differ by one or two nucleotides from on-target sites. RGEN RNPs cleave chromosomal DNA almost immediately after delivery and are degraded rapidly in cells, reducing off-target effects. Furthermore, RNP delivery is less stressful to human embryonic stem cells, producing at least twofold more colonies than does plasmid transfection.
Key Findings
1
Delivery of purified Cas9 protein complexed with guide RNA (RGEN RNPs) into human cells enables efficient site-specific genome editing.
2
RGEN RNP delivery enables editing in hard-to-transfect cells such as fibroblasts and pluripotent stem cells without introducing plasmid DNA that can integrate into the genome.
3
RGEN RNP delivery is less stressful to human embryonic stem cells, yielding at least twofold more colonies than plasmid transfection.
4
RGEN RNP delivery substantially reduces off-target mutations seen with plasmid transfection at sites differing by one or two nucleotides.
5
RGEN RNPs cleave chromosomal DNA almost immediately after delivery and are rapidly degraded in cells, contributing to reduced off-target effects.
6
RGEN RNPs induced site-specific mutation frequencies up to 79% in cultured human cells.
Research Object
Purified recombinant Cas9 ribonucleoproteins (Cas9 protein complexed with guide RNA) delivered into cultured human cells
Research Subject
Efficiency and specificity of RNA-guided genome editing mediated by delivered Cas9 RNPs in human cells, including on-target mutation frequency, reduction of off-target mutations, kinetics of DNA cleavage and RNP degradation, and effects on cell viability/colony formation compared to plasmid transfection
Publication Details
Publication Date
2014-04-02
Journal
Publisher
ISSN
Cited by
1857
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by6
The new frontier of genome engineering with CRISPR-Cas92014
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects2020
The CRISPR tool kit for genome editing and beyond2018
Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection2015
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping2020
CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenum2016